CHMP decision levels the playing field for GSK's RSV jab GSK's RSV vaccine is poised for EU approval in all adults aged 18 and over, bringing it into line with rival shots from Pfizer and Moderna.

#vaccines #immunisations #CHMP #GSK #RSVvaccine #respiratorysyncytialvirus #respiratorysyncytialvirusvaccine #RSV #Arexvy #labelexpansion #CHMPrecommendation #Pfizer #Abrysvo #Moderna #mResvia #lowerrespiratorytractdisease #LRTD #RSVdisease #RSVinfections #infectiousdiseases
zurl.co/PkV03